相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies
C. R. Rayner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics
Mohamed A. Kamal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza
David W. Kimberlin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Combined Effects of Antenatal Receipt of Influenza Vaccine by Mothers and Pneumococcal Conjugate Vaccine Receipt by Infants: Results from a Randomized, Blinded, Controlled Trial
Saad B. Omer et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Influenza Vaccination Given at Least 2 Weeks Before Delivery to Pregnant Women Facilitates Transmission of Seroprotective Influenza-specific Antibodies to the Newborn
Geraldine Blanchard-Rohner et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Oseltamivir Pharmacokinetics and Clinical Experience in Neonates and Infants during an Outbreak of H1N1 Influenza A Virus Infection in a Neonatal Intensive Care Unit
Joseph F. Standing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Oseltamivir Dosing in Premature Infants
Christopher McPherson et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Virus Load Kinetics and Resistance Development During Oseltamivir Treatment in Infants and Children Infected With Influenza A(H1N1) 2009 and Influenza B Viruses
Barbara Rath et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience
James R. Smith et al.
ADVANCES IN THERAPY (2011)
Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants
Neil Parrott et al.
CLINICAL PHARMACOKINETICS (2011)
Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir
Deshi Shi et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Determination of Appropriate Dosing of Influenza Drugs in Pediatric Patients
E. P. Acosta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Safety and pharmacokinetics of oseltamivir at standard and high dosages
R. Dutkowski et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Oseltamivir Dosing for Influenza Infection in Premature Neonates
Edward P. Acosta et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
Dongfang Yang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Population pharmacokinetics of oseltamivir when coadministered with probenecid
Craig R. Rayner et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effectiveness of maternal influenza immunization in mothers and infants
K. Zaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Population pharmacokinetic studies in pediatrics: Issues in design and analysis
B Meibohm et al.
AAPS JOURNAL (2005)
Management of influenza in households: A prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis
FG Hayden et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years
C Oo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
KG Nicholson et al.
LANCET (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
